TAMPA, Fla.—Please Join Nephros at the FMQAI: Florida End-Stage Renal Disease (ESRD) network 's 9th annual forum in Tampa, Fla. on October 24 to 26.
This years theme "Go for the Gold" reflects the commitment to the Centers for Medicare & Medicaid Services (CMS) goals to ensure patient-centered quality care that is effective, safe, efficient, equitable and timely.
The annual forum focuses on key areas of interest in the renal community, with opportunities for all disciplines to participate, including nephrologists, social workers, nurses, dietitians and technicians.
This year’s topics will include vascular access, kidney transplantation, anemia management, increased patient engagement and more.
Nephros is a global medical device company that focuses on the development and commercialization of liquid purification filters that combine a best in class purification to flow rate ratio with filter endurance.
The Dual Stage Ultrafilter (DSU) is the basis for the Nephros line of water filtration products, which includes the SSU in-line ultrafilter for bicarbonate. The patented dual stage cold sterilization ultrafilter has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites and endotoxins.
Using ultra pure water for dialysis fluid exceeds current and proposed AAMI/ANSI/ISO harmonization criteria for water quality in dialysis and has shown to assist in the reduction of patient inflammation and pharmaceuticals used in the treatment of patients suffering from ESRD thereby potentially offering a compelling health economic argument in dialysis today.
Nephros recently received the first FDA 510k clearance for their hemodiafiltration (HDF) system designed to work in conjunction with a qualified host (UF controlled) hemodialysis machine for the treatment of chronic renal failure.
For more information on Nephros visit us at: www.nephros.com